August 2022 - Page 3 of 7 - CannabisNewsWire

FridayAug 19, 2022 4:20 pm

420 with CNW — Study Suggests Cannabis Users Are Less Likely to Suffer Severe COVID-19 Infections

As the coronavirus pandemic raged on, infecting millions of people across the world and taking thousands of lives each day, there were claims that cannabis use could potentially reduce the risk of contracting the virus. Looking to ascertain whether these claims were factual, researchers began looking at the relationship between cannabis and COVID-19 and found that the controversial drug could indeed reduce the risk of developing coronavirus health complications. Researchers have now found a link between marijuana consumption and reduced coronavirus severity among patients who were hospitalized due to COVID-19 complications. They say that cannabis could potentially lower the severity…

FridayAug 19, 2022 10:30 am

NECANN 3rd Annual New Jersey Cannabis Convention Brings the East Coast Cannabis Community under One Roof

The NECANN Conference has evolved into the largest conference on the East Coast, attracting cannabis cultivators, traders, regulators, lawmakers, and enthusiasts, from the East Coast and beyond. The 3rd annual New Jersey Cannabis Convention is being held from September 9-10, 2022, in Atlantic City, New Jersey. This is a well-curated event organized by a highly talented team of professionals with desired expertise and experience. They keep in mind the needs and requirements of the cannabis community and bring together investors, young and veteran cannabis and hemp traders, as well as researchers and lawmakers, all in a common forum. After fighting…

FridayAug 19, 2022 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application

Lexaria’s successful HYPER-H21-2 human clinical study, whose results were announced in the first week of September 2021, laid the groundwork for the company’s patented DehydraTECH(TM)-processed CBD NDA Chris Bunka, the company’s CEO, referred to the results as “statistically significant,” ultimately kickstarting the IND application process with the FDA Lexaria has since received a full written positive response from the FDA on its DehydraTECH-CBD, agreeing to the company’s proposal to pursue the 505(b)(2) NDA regulatory pathway As a result of the favorable FDA response, Lexaria expects to remain on track to file its full IND application, 6-9 months sooner than if…

FridayAug 19, 2022 4:20 am

420 with CNW — Influential Nonprofit Says Federal Cannabis Bill Insufficient to Fix Harms of Drug War

The war on drugs was ostensibly started to mitigate drug addiction rates in the country and deal a blow to the criminal enterprises behind the illicit drug trade. However, most experts agree that the decades-long drug war was a failure, leading to the arrest and incarceration of tens of thousands of people on minor drug charges. Furthermore, the drug war exacerbated racial and economic inequality in the country and caused nigh-irreparable damage to marginalized communities. As cannabis reform has swept across America, most activists and lawmakers have championed cannabis legalization measures that contain social equity provisions designed to repair the…

ThursdayAug 18, 2022 4:20 pm

420 with CNW — State Data Says Michigan Cannabis Sales Broke Monthly Record in July

The Cannabis Regulatory Agency in the state of Michigan recently published data showing that the state set a new record for cannabis sales last month. The state reached almost $210 million in total marijuana sales, recording more than $188 million in adult-use cannabis purchases and more than $21 million in medical marijuana sales in the month of July. This total is almost $15 million higher than the previous record the state set earlier in the year. The majority of the cannabis purchases for both recreational and medical use were for flower products, with vape cartridges coming in second. The data…

ThursdayAug 18, 2022 4:20 am

420 with CNW — Alcohol vs. Marijuana: How These Industries Are Coping with Inflation

Many often look at the alcohol industry as a way to get ideas about the trajectory that the nascent marijuana industry could take, and this comparison couldn’t be more necessary at this time when inflation is soaring, and different sectors are reeling. Let’s take a look at these two industries to see how exactly they are being impacted by inflation and how they are coping. As you may be aware, alcohol is legal at the federal level and can be bought in a variety of places, including restaurants, bars and even convenience stores. This varied access somehow provides a cushion…

WednesdayAug 17, 2022 4:20 pm

420 with CNW — Another Push Is Underway in Florida to Legalize Recreational Cannabis

Floridians could be able to purchase and use recreational cannabis legally in the next few years if a proposed constitutional amendment that was filed last week is successful. Backed by country-music duo the Bellamy Brothers and Trulieve, currently the largest medical-cannabis operator in Florida, the measure would legalize the use of recreational marijuana by people aged 21 and older. The Tallahassee-based medical marijuana operator contributed $5 million to help get the constitutional amendment to the 2024 ballot. The measure is also expected to receive support from other multistate medical cannabis companies. The proposed amendment was filed on Monday at the…

WednesdayAug 17, 2022 4:20 am

420 with CNW — Florida Agriculture Commissioner Calls DOJ Memo on Gun Rights Lawsuit Insulting

The agriculture commissioner in Florida has described as “insulting” the memo the U.S. Department of Justice filed supporting its motion to dismiss a lawsuit challenging the denial of the right to buy a firearm by users of medical marijuana. The said lawsuit was filed by Commissioner Nikki Fried in April 2022. No one is surprised that the DOJ asked the court to dismiss this lawsuit, but the contents of the memo the federal agency penned has attracted widespread criticism from several quarters. For starters, advocates have taken exception to the description of medical marijuana users, such as terminally ill cancer…

TuesdayAug 16, 2022 4:20 pm

420 with CNW — Study Finds Marijuana Legalization Reduces Incidents of Synthetic Cannabinoid Poisoning

Although synthetic cannabinoids such as Spice and K2 are much more potent than natural cannabinoids, they are often mixed with dangerous chemicals, including stimulants, blood thinners and opioids that can make them deadly. An outbreak of synthetic cannabinoids contaminated with anticoagulants in 2018 caused excessive bleeding that affected more than 300 people and took at least eight lives. A study using data sourced from the National Poison Data System (NPDS) recently revealed that states with legal marijuana access record significantly fewer synthetic cannabinoid poisoning cases. Study authors hypothesize that cannabis policies that allow legal sales provide little incentive for people…

TuesdayAug 16, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Four Partnerships, Boosts ‘Revenue Picture’

Lexaria Bioscience, a global innovator in drug delivery platforms, recently announced partnerships with Premier Wellness Science Co., BevNology, AnodGen Bioceuticals, and Valcon Medical A/S According to coverage by Zacks Small-Cap Research, who value Lexaria at $15 per share, the most impactful of these partnerships is with Premier because the company is expected to start paying license fees in early September In a June 7 Fireside Chat, Lexaria Chair and CEO Chris Bunka disclosed that the company is capitalizing on partnerships with “national players in different areas of the world” to improve its “revenue picture” and offset its cash burn In…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Month: August 2022